Follow The Filings

FDMT 4D Molecular Therapeutics

4D Molecular Therapeutics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -1.04 —
Rev — $100.0K —

Insider trades

Open-market buys and sales by FDMT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FDMT insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $5.4M sold by 2 insiders under 10b5-1 plans
  1. Scott Bizily Chief Legal Officer
    Planned sale
    $21K 1,635 shares at $12.84 16% of stake
    Traded Oct 16 Filed Oct 20
    ↗
  2. David Kirn See Remarks
    Planned sale
    $754K 58,333 shares at $12.92 7.6% of stake
    Traded Oct 5 Filed Oct 7
    ↗
  3. Scott Bizily Chief Legal Officer
    Planned sale
    $22K 1,635 shares at $13.65 16% of stake
    Traded Sep 16 Filed Sep 22
    ↗
  4. David Kirn See Remarks
    Planned sale
    $811K 58,333 shares at $13.90 7.1% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  5. Scott Bizily Chief Legal Officer
    Planned sale
    $8,176 584 shares at $14.00 6.3% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  6. David Kirn See Remarks
    Planned sale
    $1.1M 69,076 shares at $15.75 7.7% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  7. Scott Bizily Chief Legal Officer
    Planned sale
    $40K 3,270 shares at $12.10 28% of stake
    Traded Aug 13–17 Filed Aug 17
    ↗
  8. David Kirn See Remarks
    Planned sale
    $275K 26,842 shares at $10.23 3.1% of stake
    Traded Aug 4 Filed Aug 5
    ↗
  9. David Kirn See Remarks
    Planned sale
    $125K 12,415 shares at $10.05 1.4% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  10. David Kirn See Remarks
    Planned sale
    $737K 58,333 shares at $12.64 6.2% of stake
    Traded Jul 9–10 Filed Jul 14
    ↗
  11. Scott Bizily Chief Legal Officer
    Planned sale
    $92K 6,566 shares at $14.00 43% of stake
    Traded Jun 30 Filed Jul 2
    ↗
  12. Scott Bizily Chief Legal Officer
    Planned sale
    $118K 9,810 shares at $12.00 53% of stake
    Traded Jun 23 Filed Jun 25
    ↗
  13. David Kirn See Remarks
    Planned sale
    $1.2M 114,746 shares at $10.47 11% of stake
    Traded Jun 22 Filed Jun 23
    ↗
  14. David Kirn See Remarks
    Planned sale
    $19K 1,922 shares at $10.02 0.2% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  15. Scott Bizily Chief Legal Officer
    Planned sale
    $18K 1,635 shares at $10.90 31% of stake
    Traded Dec 16, 2025 Filed Dec 19, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises and 4 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,2.03 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.